A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body
Clinical trial NCT07215260 · COMPLETED
Trial details
- NCT number
- NCT07215260
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-05
- Primary completion
- 2025-12-07
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.